Sun Pharmaceutical Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA9,32711,3190
EBIT2,9414,6090
Earning Per Share121335
Expenses25,03028,41132,239
Net Profit2,2853,4068,561
Net Profit Margin7920
Operating Profit Margin282928
Profit Before Tax2,7994,4819,408
Dividends Per Share8100
Operation Revenue34,35739,73044,520

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Sun Pharmaceutical is 0 as of 2/20/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20032003200320032023
Operating Activities1511511511514,959
Investing Activities-77-77-77-77-7,944
Financing Activities737373732,376
Others00000
Net Cash Flow147147147147-608

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of Sun Pharmaceutical is 4,959 as of 2/20/2024